Onapristone has been used in trials studying the treatment of Prostate Cancer, Recurrent Prostate Cancer, Metastatic Prostate Cancer, Androgen-independent Prostate Cancer, and Progesterone Receptor Positive Tumor: Max 1 Line of Prior Chemotherapy, no Prior Hormone Therapy. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include Onapristonum, ZK-98299, 11beta-(p-(Dimethylamino)phenyl)-17alpha-hydroxy-17-(3-hydroxypropyl)-13alpha-estra-4 and 9-dien-3-one. Its PubChem CID is 5311505.
Onapristone
| CAS No | 96346-61-1 |
|---|---|
| Molecular Formula | C29H39NO3 |
| Molecular Weight | 449.6 g/mol |
| Synonyms | (8S,11R,13R,14S,17S)-11-[4-(dimethylamino)phenyl]-17-hydroxy-17-(3-hydroxypropyl)-13-methyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Onapristone has been used in trials studying the treatment of Prostate Cancer, Recurrent Prostate Cancer, Metastatic Prostate Cancer, Androgen-independent Prostate Cancer, and Progesterone Receptor Positive Tumor: Max 1 Line of Prior Chemotherapy, no Prior Hormone Therapy.
The listed CAS number is 96346-61-1.
The listed molecular formula is C29H39NO3.
The listed molecular weight is 449.6 g/mol.
(8S,11R,13R,14S,17S)-11-[4-(dimethylamino)phenyl]-17-hydroxy-17-(3-hydroxypropyl)-13-methyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one.
The source lists Onapristonum, ZK-98299, 11beta-(p-(Dimethylamino)phenyl)-17alpha-hydroxy-17-(3-hydroxypropyl)-13alpha-estra-4 and 9-dien-3-one.